Cryo-Save Group N.V. (Euronext: CRYO, 'Cryo-Save', or 'the Group'), the leading international stem cell storage company and the largest family stem cell bank in Europe, announces that it has completed the tranche of its share buyback programme as announced on 30 January 2013.
The Group has purchased 1,597 shares and has reached an agreement with a shareholder regarding the buyback of 120,000 shares via its bank Kempen & Co. The share purchase and the block trade are part of the share buyback programme as announced yesterday. Cryo-Save repurchased these 121,597 shares at an average price of € 2.34.
These shares together with the 364,000 treasury shares that are already in the possession of the Group, representing 5% of the issued shares, will be proposed for cancellation by the Board at the upcoming Annual General Meeting on 15 May 2013.
Enquiries:
Cryo-Save Group, Arnoud van Tulder, Chief Executive Officer + 31 (0) 575 509 100